Oct 8 (Reuters) – ONO PHARMACEUTICAL CO., LTD.: * BIOHAVEN ENTERS STRATEGIC LICENSING AGREEMENT WITH ONO PHARMA FOR EXTRACELLULAR IGG DEGRADERS IN JAPAN AND SELECT ASIAN REGIONS, LEAD CANDIDATE BHV-
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Corrects paragraph 1 to say previous rate hike was in February 2023, not December 2023)…
By Anuja Bharat Mistry and Alexander Marrow Oct 8 (Reuters) - PepsiCo warned on Thursday…
By Kyu-seok Shim and Brenda Goh SEOUL, Oct 8 (Reuters) - The suspect behind recent…
FRANKFURT, Oct 8 (Reuters) - Euro zone inflation could turn out higher than projected but…
VIDEO SHOWS: BERLIN HOTEL WHERE UEFA MEETS / INTERVIEW WITH UEFA VICE PRESIDENT HANS-JOACHIM WATZKE …
New Delhi [India], October 8: Garmin has received the ‘Most Advanced Health Monitoring Smartwatch’ award…